Latest 10-K annual reports

BAB, Inc. announced a rise in net income and earnings per share for fiscal year 2025, despite a slight decrease in total revenues and unit count.

Constellation Energy reports a decrease in GAAP Net Income for 2025 despite strategic Calpine acquisition and strong operational performance in its clean energy fleet.

The Chefs' Warehouse reported robust 9.4% net sales growth in fiscal 2025, driven by organic expansion and strategic acquisitions, while also amending its credit agreement to reduce interest rates on term loans.

McDonald's Corporation reports robust 2025 financial performance with global comparable sales up 3.1% and Systemwide sales increasing 7%, driven by its Accelerating the Arches strategy and significant restaurant expansion.

Iovance Biotherapeutics reports increased Amtagvi revenue and ongoing clinical trials, alongside a net loss of $391.0 million for fiscal year 2025.

Allison Transmission Holdings, Inc. reports a 7% decrease in 2025 net sales to $3.01 billion, driven by North America On-Highway and Global Off-Highway declines, while completing a significant acquisition to diversify its off-highway business.

Elanco Animal Health reported a net loss of $232 million in 2025, driven by significant restructuring charges and asset impairments, despite revenue growth and new product launches.

Cipher Digital Inc. (formerly Cipher Mining Inc.) is strategically shifting from bitcoin mining to high-performance computing (HPC) data center development, securing major leases with Amazon and Fluidstack/Google, despite reporting a significant net loss of $822.2 million in 2025.

Mohawk Industries reports a decrease in 2025 net earnings and operating income amidst challenging market conditions, while pursuing strategic restructuring and product innovation.

Harmony Biosciences reports strong 2025 revenue growth for WAKIX, expands its neuroscience pipeline, and navigates generic competition.

Portillo's Inc. reported a 3.0% revenue increase to $732.1 million in fiscal 2025, but net income and EBITDA declined, prompting a strategic reset in its new restaurant expansion approach.

Artelo Biosciences reported promising interim clinical trial results for its drug candidates but faces substantial doubt about its ability to continue as a going concern and a Nasdaq delisting threat due to insufficient stockholders' equity.

Shoals Technologies Group, a leader in solar and BESS electrical infrastructure, reported a 19% revenue increase in 2025, driven by higher demand for utility-scale solar projects.

The Chemours Company reported a significant net loss in 2025, driven by substantial litigation charges and operational challenges in its Titanium Technologies and Advanced Performance Materials segments, despite growth in Thermal & Specialized Solutions.

First Watch Restaurant Group, Inc. reported a 20.3% increase in total revenues to $1.2 billion in 2025, driven by new restaurant openings and positive same-restaurant sales growth, despite commodity and labor inflation.

Beam Therapeutics reported positive Phase 1/2 clinical data for its sickle cell disease candidate, risto-cel, and secured a $500 million credit facility, while continuing to advance its broad gene editing pipeline.

Fulcrum Therapeutics' 2025 annual report highlights promising Phase 1b pociredir data for sickle cell disease and a strengthened financial position, despite a significant net loss.

Orthofix Medical Inc. reported 2025 net sales of $822.3 million, a 2.9% increase, alongside strategic discontinuation of M6 artificial disc product lines and ongoing legal proceedings involving former executives.

Armstrong World Industries, Inc. reported a significant increase in net sales and operating income for 2025, driven by strategic acquisitions and favorable average unit value.

Life Time Group Holdings, Inc. achieved record revenue and significant net income growth in 2025, driven by strong membership engagement and strategic expansion.

Apellis Pharmaceuticals achieved its first net income of $22.4 million in 2025, driven by strong licensing revenue and continued commercialization of SYFOVRE and EMPAVELI, despite a decline in SYFOVRE sales.

Innovative Industrial Properties, Inc. reports significant financial declines and a going concern warning due to debt maturity, while strategically expanding into life science investments.

Clarivate Plc reported a 4% revenue decline in 2025 to $2.46 billion, alongside a significantly reduced net loss and increased free cash flow, as it executes its Value Creation Plan focused on AI innovation and business streamlining.

World Kinect Corporation reported a significant net loss of $614.4 million for fiscal year 2025, primarily driven by substantial goodwill impairments and restructuring costs in its land segment, despite growth in aviation gross profit.

Dream Finders Homes reports a decline in net income and homebuilding gross margin for 2025 amidst macroeconomic challenges, while strategically expanding its market presence and financial services.

Landstar System reports a 2% revenue decrease and significant impairment charges in fiscal year 2025, impacting net income and EPS.

Monarch Casino & Resort, Inc. announced a significant increase in net income and diluted EPS for 2025, driven by casino revenue growth, despite ongoing litigation costs related to its Black Hawk expansion.

Valmont Industries, Inc. reported a slight increase in net sales for fiscal year 2025, driven by Infrastructure growth but offset by declines in Agriculture, alongside significant impairment charges.

Paymentus Holdings, Inc. announced robust financial results for fiscal year 2025, driven by significant transaction volume growth and increased profitability, despite moderating inflation.

Diversified Healthcare Trust reported a reduced net loss and increased total NOI in 2025, driven by strong SHOP performance and strategic asset sales, despite a decline in FFO and negative operating cash flow.